03:24 AM EDT, 10/03/2025 (MT Newswires) -- Joseph H Wender, Director, on October 01, 2025, sold 16,800 shares in Ionis Pharmaceuticals ( IONS ) for $1,100,385. Following the Form 4 filing with the SEC, Wender has control over a total of 92,035 common shares of the company, with 92,035 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/874015/000087401525000246/xslF345X05/edgardoc.xml ...

03:23 AM EDT, 10/03/2025 (MT Newswires) -- Patrick R. O'Neil, Executive Vice President, Chief Legal Officer & General Counsel, on October 02, 2025, sold 64,664 shares in Ionis Pharmaceuticals ( IONS ) for $4,377,054. Following the Form 4 filing with the SEC, O'Neil has control over a total of 57,130 common shares of the company, with 57,130 shares held directly....

03:23 AM EDT, 10/03/2025 (MT Newswires) -- Eric Swayze, Executive Vice President, Research, on October 01, 2025, sold 27,114 shares in Ionis Pharmaceuticals ( IONS ) for $1,793,744. Following the Form 4 filing with the SEC, Swayze has control over a total of 37,486 common shares of the company, with 37,302 shares held directly and 184 controlled indirectly. SEC Filing:...

03:25 AM EDT, 10/03/2025 (MT Newswires) -- Jacob Chacko, Director, President and Chief Executive Officer, on September 30, 2025, sold 87,539 shares in Oric Pharmaceuticals ( ORIC ) for $1,053,555. Following the Form 4 filing with the SEC, Chacko has control over a total of 568,880 common shares of the company, with 568,880 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1796280/000160893625000008/xslF345X05/form4-10022025_111028.xml ...